Correcting the reward imbalance in binge eating: A pilot randomized trial of reward re-training treatment

Appetite. 2022 Sep 1:176:106103. doi: 10.1016/j.appet.2022.106103. Epub 2022 Jun 1.

Abstract

Behavioral treatments for psychological disorders characterized by reward-driven maladaptive behaviors (e.g., substance use disorder, eating disorders, behavioral addictions) primarily seek to reduce hyper-reward response to disorder-specific stimuli. Suboptimal outcomes for these treatments highlight the need to also target hypo-reward response to day-to-day life activities. The present study sought to conduct an initial test of a novel behavioral treatment, Reward Re-Training (RRT) to target hyper- and hypo-reward response in individuals with binge eating. Individuals with binge eating (N = 23) were randomly assigned to either 10 weeks of outpatient, group-based RRT treatment or a waitlist control. RRT was found to be feasible and acceptable, demonstrated large impacts on both hypo- and hyper-reward response (measured by self-report (pre-to post-treatment ηp2 range 0.38-0.58) and neural activation via fMRI), and was efficacious in reducing eating disorder pathology (ηp2 range 0.40-0.64, including binge eating, ηp2 = 0.64) compared to waitlist control (ηp2 range 0.00-0.04). This pilot data provides preliminary support for the feasibility, acceptability, and effectiveness of a novel treatment targeting reward imbalance for individuals with binge eating. Future evaluations of RRT may benefit from an active treatment comparison condition and a follow-up assessment to examine persistence of positive outcomes.

Trial registration: ClinicalTrials.gov NCT03942874.

Keywords: Binge eating; Group treatment; Reward imbalance.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Behavior Therapy
  • Binge-Eating Disorder* / psychology
  • Binge-Eating Disorder* / therapy
  • Feeding and Eating Disorders*
  • Humans
  • Pilot Projects
  • Reward
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT03942874